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Linnea Swanson1, Randy S. Daughters2, Devavani Chatterjea1*
1 Department of Biology, Macalester College, St. Paul, Minnesota, United States of America, 2 Stem Cell Institute, University of Minnesota, Minneapolis,
Minnesota, United States of America
Abstract
The interplay among pain, allergy and dysregulated inflammation promises to yield significant conceptual advances
in immunology and chronic pain. Hapten-mediated contact hypersensitivity reactions are used to model skin allergies
in rodents but have not been utilized to study associated changes in pain perception in the affected skin. Here we
characterized changes in mechanical hyperalgesia in oxazolone-sensitized female mice challenged with single and
repeated labiar skin exposure to oxazolone. Female mice were sensitized with topical oxazolone on their flanks and
challenged 1-3 times on the labia. We then measured mechanical sensitivity of the vulvar region with an electronic
pressure meter and evaluated expression of inflammatory genes, leukocyte influx and levels of innervation in the
labiar tissue. Oxazolone-sensitized mice developed vulvar mechanical hyperalgesia after a single labiar oxazolone
challenge. Hyperalgesia lasted up to 24 hours along with local influx of neutrophils, upregulation of inflammatory
cytokine gene expression, and increased density of cutaneous labiar nerve fibers. Three daily oxazolone challenges
produced vulvar mechanical hyperalgesic responses and increases in nerve density that were detectable up to 5
days post-challenge even after overt inflammation resolved. This persistent vulvar hyperalgesia is resonant with
vulvodynia, an understudied chronic pain condition that is remarkably prevalent in 18-60 year-old women. An
elevated risk for vulvodynia has been associated with a history of environmental allergies. Our pre-clinical model can
be readily adapted to regimens of chronic exposures and long-term assessment of vulvar pain with and without
concurrent inflammation to improve our understanding of mechanisms underlying subsets of vulvodynia and to
develop new therapeutics for this condition.
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Introduction
Rodent models of contact hypersensitivity (CHS) help
elucidate the underlying mechanisms of skin allergies such as
atopic dermatitis [1,2]. The CHS response to the hapten
oxazolone (Ox) depends on mast cell immunoglobulin (Ig) E
[3,4], and is accompanied by tissue edema [3,5], upregulation
of inflammatory cytokines [4,6,7] and mast cell-dependent
cutaneous nerve elongation [5]. However, mechanistic
connections between allergic reactions and subsequent
changes in pain perception in the skin remain largely
understudied. Provoked, burning vulvar pain, or vulvodynia [8]
has been associated with a history of seasonal allergies [9].
Women with vulvodynia show increased mast cell numbers in
vulvar biopsies [10] and hyper-innervation of the vulvo-
vestibular tissue [11,12] suggesting that underlying pathological
mechanisms may be similar to those reported in rodent models
of Ox-CHS [5].
Here we demonstrate that in Ox-sensitized female ND4
Swiss mice, a single labiar Ox challenge provokes vulvar
mechanical hyperalgesia for up to 24 hours and is
accompanied by neutrophil influx, upregulation of inflammatory
cytokine gene expression, and increased density of cutaneous
calcitonin gene related peptide (CGRP)+ and protein gene
product 9.5 (PGP 9.5)+ nerve fibers. Following 3 daily
consecutive Ox challenges, vulvar hyperalgesia persists for up
to 5 days, after the tissue markers of overt inflammation have
resolved, demonstrating long-term changes in mechanical
sensitivity in the affected skin.
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We provide the first evidence of induction of measurable
CHS-associated hyperalgesia in mice and establish the first
pre-clinical model of allergen-provoked vulvar pain. The model
we present here can be adapted to chronic labiar allergen
exposures and long-term assessment of pain with and without
ongoing inflammation to dissect the complex interplay between
allergies and chronic pain in vulvodynia and beyond.
Materials and Methods
Ethics statement and animal usage
8-12 week old female ND4 Swiss mice (Harlan Laboratories,
Indianapolis, IN) were housed in Macalester College’s animal
facility in accordance with National Institutes of Health-
approved guidelines, with a 12-hour light/dark cycle and free
access to food and water, and were used with Institutional
Animal Care and Use Committee approval (Macalester College
IACUC protocols B11F1 and B13S1) for these studies.
Drug administration
Mice were sensitized with topical application of 2% Ox (100
µl; Sigma-Aldrich, St. Louis, MO) on their shaved flanks on day
1, and challenged on the shaved labia with 1% Ox (40 µl) or
vehicle (100% ethanol; EtOH) on day 5 [5] or on days 5-7 [13]
(Figure S1). Treatments were performed at the same time of
day as circadian regulation can affect CHS [14].
Mechanical hyperalgesia assessment
To measure vulvar sensitivity, mice were stimulated along
the ano-genital ridge with a semi-flexible polypropylene tip
fitted to an electronic von Frey pressure meter (IITC Life
Science, Woodland Hills, CA) until they demonstrated one or
more nociceptive behaviors: genital licking, lower abdomen
retraction, a back paw jump, or a four paw jump [15]. Baseline
measurements were taken 24 and 48 hours before
sensitization; of 5 baseline measurements per mouse, three
closest to the median were averaged to obtain the baseline
withdrawal threshold as previously described [16]. Mice with
baseline withdrawal threshold average lower than 0.50 grams
and mice with baseline thresholds differing by more than 1.00
gram were excluded from the experiment. Remaining mice
were assigned to treatment groups such that average baseline
thresholds across treatment groups were as similar as possible
as previously described [16]. Experimental withdrawal
threshold was calculated as the average of 3-4 measurements
taken at stated time points after Ox challenge [17]. Delta
withdrawal threshold for each mouse was obtained by
subtracting its own average baseline from its own average
experimental threshold. At least 10 mice were used per
treatment group for each experiment and data shown represent
2-3 independent experiments. After hyperalgesia
measurements were performed, mice were euthanized and 3-6
mice per treatment group from each experiment were used for
the analyses described below.
Quantification of vulvar myeloperoxidase activity
Labia were preserved and processed as described [17], and
absorbance measured at 450 nm to measure myeloperoxidase
activity (normalized to tissue weight, and represented as optical
density i.e. OD/g of wet tissue).
RNA isolation and quantitative real-time RT-PCR (qRT-
PCR)
Total RNA was extracted from flash-frozen labiar tissue
(Total RNA Mini Kit, Midwest Scientific, St. Louis, MO),
quantified with Nanodrop ND-1000 Spectrophotometer
(ThermoScientific, Wilmington, DE), and reverse-transcribed in
a 2720 Thermal Cycler (Life Technologies, Grand Island, NY)
using Superscript III First-Strand Synthesis System (Life
Technologies) with 100ng of RNA per reaction. Transcripts
were quantified using TaqMan Gene Expression Assay Primer/
Probe Sets and TaqMan Master Mix (Life Technologies) in a
Bio-Rad iCycler (Bio-Rad, Hercules, CA) using β-2-
microglobulin (β2m; Mm00437762_m1), interleukin-1β (IL-1β;
Mm00434228_m1), tumor necrosis factor-α (TNF-α;
Mm00443260_g1), interleukin-6 (IL-6; Mm00446190_m1),
chemokine (C-X-C motif) ligand 2 (CXCL2; Mm00436450_m1),
chemokine (C-X-C motif) ligand 1 (CXCL1; Mm04207460_m1),
and interferon- γ (IFN-γ; Mm01168134_m1) primer/probe sets,
normalized to β2m, and calculated as fold-expression over
controls [18].
Immuno-fluorescent staining and analysis
Labiar tissue samples embedded in Optimal Cutting
Temperature compound (Sakura Finetek, Torrance, CA) and
snap frozen over liquid nitrogen were cryo-sectioned (16-20
µm), post-fixed in 2% paraformaldehyde (Sigma-Aldrich; pH
8.5) for 5 minutes (room temperature), permeabilized with 0.1%
Triton/PBS for 10 minutes, blocked with 5% normal goat
serum/PBS, incubated overnight (4°C) with 1:400 anti-CGRP
(Abbiotec, San Diego, CA) and then with Alexa Fluor 488-
conjugated secondary antibody (Life Technologies; 1:1000) in
blocking solution for 2 hours (room temperature). Slides were
cover-slipped with Vectashield + DAPI (Vector Laboratories,
Burlingame, CA). We performed a quantitative assessment of
nerve density on images obtained from confocal sections and
analyzed using Fluoview 1000 image analysis software
(Olympus Corporation, Center Valley, PA). Nerve density
values were determined from randomly chosen regions of
interest within tissue sections and were defined as the
fluorescent pixel intensity of CGRP or PGP9.5 labeled nerves
within a 5mm2 area. Average density values per sample (n=3
per treatment group) were calculated from four regions of
interest per section for five sections per sample. Each image
analyzed was a composite of fifteen optical sections projected
along the z-axis in 1µm increments.
Statistical analysis
Data were processed with Excel (Microsoft, Redmond, WA),
graphed with PRISM 5.0 (GraphPad, San Diego, CA) and
shown as mean ± SEM. One-way ANOVA and Tukey HSD
post hoc analysis were performed using JMP Software (v. 9.0)
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(SAS, Cary, NC). Statistical significance was defined as
p<0.05.
Results
Single vulvar Ox challenge caused allergic vulvar
hyperalgesia, neutrophil influx and upregulation of
inflammatory gene expression in Ox-sensitized female
ND4 Swiss mice
Oxazolone-sensitized ND4 Swiss mice were significantly
more sensitive to vulvar mechanical pressure measured at 1, 3,
6, and 24 hours after when challenged on day 4 following
sensitization with 1% Ox on the labia compared to vehicle-
challenged controls; hyperalgesia peaked at 24 hours and
resolved by 48 hours (Figure 1A). Farmer and colleagues [15]
have previously defined hyperalgesic mice as those that have
33% or greater reduction in experimental vulvar withdrawal
thresholds compared to baseline. Using this criterion, we found
that following a single Ox challenge, 67-100% of mice were
hyperalgesic compared to 0-12.5% of vehicle-challenged mice
over the time points at which mechanical sensitivity was
significantly different between treatment groups (Table 1).
Neither the mice’s stage of estrous nor Ox sensitization alone
produced hyperalgesic responses (Figure S2A-B). Sensitivity
was restricted to the Ox challenge site and could not be
detected in the hind paw (Figure S2C).
We next examined leukocyte infiltration and inflammatory
cytokine gene expression in the labia. Vulvar myeloperoxidase
activity indicating infiltrating neutrophils [17] was higher in
homogenates from Ox- vs. vehicle-challenged mice at 6, 24,
and 48 hours, peaking at 24 hours (Figure 1B). Transcripts
encoding cytokines that mediate inflammatory hyperalgesia in
rodents [19–21] were markedly upregulated - CXCL2 (~20-
fold), IL-6 (~60-fold), CXCL1 (~25-fold), IFN-γ(~25-fold), IL-1β
(~18-fold) and TNF-α (~5-fold) - in Ox-challenged vs. vehicle-
treated controls at 24 hours but largely resolved by 48 hours
after challenge, except for CXCL2 expression which was
variable but remained at around 20-30 fold over ethanol-
challenged controls (Figure 1C). IL-1β and TNF-α are some of
the earliest cytokines expressed following skin inflammation
[22]; here we found that IL-1β transcripts were markedly
elevated ~60-fold in Ox challenged mice vs. controls as early
as 6 hours after a single challenge but there was only a slight
increase (<5-fold) in TNF-α mRNA levels compared to controls
at this early time point (Figure S3).
In sum, Ox-provoked vulvar CHS caused pronounced
mechanical hyperalgesia accompanied by neutrophil influx and
increase in inflammatory cytokine gene expression.
Repeated Ox challenge caused persistent vulvar
hyperalgesia in sensitized female ND4 Swiss mice after
resolution of overt tissue inflammation
We investigated whether repeated Ox challenges in the skin
produced longer-lasting vulvar hyperalgesic responses
compared to a single challenge. We found that 3 daily labiar
challenges with Ox produced expected vulvar mechanical
sensitivity at 6 and 24 hours after the third challenge. These
responses then persisted for up to 5 days (120 hours) and
resolved by 10 days (240 hours) post-challenge (Figure 2A). Of
mice challenged thrice with Ox, 70-83% were hyperalgesic
(experimental latencies ≤ 33% of their baseline responses)
over the time points at which mechanical sensitivities were
significantly different between treatment groups (Table 1).
Changes in vulvar sensitivity remained localized to site of
challenge (data not shown).
At 24 hours post-challenge, tissue myeloperoxidase levels
increased > 2-fold in Ox triple-challenged mice vs. controls. By
5 days (120 hours) after the third challenge, there were no
differences in myeloperoxidase activity levels between
experimental and control mice (Figure 2B). CXCL2 transcripts
increased ~160-fold over controls at 24h after 3 consecutive Ox
challenges but were reduced to <10-fold by 5 days; 24 hours
after the third challenge, IL-6 transcripts were ~ 75-fold more
abundant over controls, IL-1β ~ 30-fold elevated over controls.
CXCL1 was 15-fold higher than controls, while IFN-γ and TNF-
α mRNAs showed little to no increase (Figure 2C). Similar to
our observations following a single Ox challenge, we found that
IL-1β transcripts were upregulated ~ 12-fold in Ox challenged
mice vs. controls as early as 6 hours after the third challenge
but there were no changes in TNF-α mRNA levels compared to
controls at this early time point (Figure S3). As multiple Ox
challenges can induce a Th2 cytokine profile [23], we assessed
interleukin-4 (IL-4) gene expression 24 hours after 3 Ox
challenges. We observed a very slight increase in triple-
challenged mice but detected no IL-4 transcription in untreated
and vehicle-challenged controls (Table S1).
Therefore, vulvar mechanical hyperalgesia persisted for 5
days following 3 daily challenges with Ox in sensitized mice
after increases in neutrophil influx and inflammatory cytokine
gene expression had resolved to control levels.
Density of CGRP+ and PGP 9.5+ cutaneous nerves in the
labiar skin of Ox-sensitized female ND4 Swiss mice
increased after single and repeated Ox challenges
Increased cutaneous innervation has been reported in
mouse models of Ox-mediated CHS [5] and in human atopic
dermatitis [24]. We found 8-10-fold increase in densities of
CGRP+ (Figure 3A-C, D) and PGP 9.5+ (Figure 3E-G, H) nerve
fibers in sensitized mice challenged once with Ox vs. vehicle
48 hours after challenge. Densities of CGRP+ (Figure 4A-C, D)
and PGP 9.5+ (Figure 4E-G, H) cutaneous nerve fibers in the
labiar skin 5 days after 3 daily Ox challenges were 6-8 fold
greater in Ox triple-challenged skin vs. untreated and vehicle-
challenged controls. CGRP labels a subset of nociceptive
neurons in contrast to the pan-neuronal marker PGP 9.5 [5];
accordingly, we visually observed more cutaneous staining with
the latter vs. the former marker. However, the fold increases in
cutaneous density seen after 1 or 3 Ox challenges were
comparable for both neuronal markers with a slightly smaller
increase observed at 120 hours after 3 challenges compared to
48 hours after a single challenge.
Discussion
Ox-mediated CHS produces vulvar mechanical hyperalgesia,
infiltration of neutrophils, upregulation of inflammatory cytokine
Allergic Mechanical Hyperalgesia in Mice
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transcripts, and increased innervation of the labiar skin in ND4
female mice. This is the first demonstration of CHS-associated
hyperalgesia, and allergy-evoked vulvar mechanical
hyperalgesia in rodents. These findings will be particularly
Figure 1.  Labiar oxazolone challenge induces acute vulvar mechanical hyperalgesia in sensitized female ND4 Swiss
mice.  Mice that received a single oxazolone challenge following sensitization show increased mechanical hyperalgesia (A),
increased myeloperoxidase activity in the labiar tissue (B), and increased abundance of CXCL2, IL-6, CXCL-1, IFN-γ, IL-1β, and
TNF-αmRNAs (C). Significances are compared to Ox/EtOH (* = p<0.05, ** = p<0.01, *** = p< 0.0001respectively). n=3-10 mice per
treatment group; data represent at least 2-3 independent experiments.
doi: 10.1371/journal.pone.0078673.g001
Allergic Mechanical Hyperalgesia in Mice
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important in elucidating the atopic mechanisms underlying
vulvodynia – a chronic vulvar pain condition that is remarkably
prevalent, poorly understood, and epidemiologically associated
with histories of environmental allergies [8,9].
Mechanistic connections between allergies and pain have
not been extensively studied. One study showed transient
hyperalgesic responses following passive cutaneous
anaphylaxis (PCA) in rats [25]. Our unpublished data indicate
that pronounced thermal and mechanical hind paw
hyperalgesia caused by PCA reactions in the footpad lasts up
to 6 hours in mice. Active immunization and challenge with
ovalbumin also caused neutrophil-dependent thermal
hyperalgesia in the hind paw for up to 6 hours in rats [26].
Here, Ox-CHS provokes pronounced vulvar mechanical
hyperalgesia for up to 24 hours after a single challenge and up
to 5 days following 3 challenges.
Ox-sensitization has previously been shown to be mast cell
dependent [3], and here we observed detectable mast cell
degranulation (via reduction in tissue histamine content) in the
elicitation phase 24 hours after a single Ox challenge but no
difference at 24 hours after 3 Ox challenges (data not shown).
We have previously shown that mast cell degranulation
regulates compound 48/80-provoked short-term thermal and
mechanical hyperalgesia in mice, which was abrogated by
mast cell granule stabilization as well as in congenital mast cell
deficiency [17]. However, here we observed that pre-treatment
with sodium cromoglycate (SCG) – a compound that can act as
a mast cell granule stabilizer [17] – reduced Ox-CHS
hyperalgesia at 1 and 6 hours but not at 24 hours when
administered 1 hour prior to Ox challenge in sensitized mice
(Figure S4). It is important to note, though, that SCG can act
through mast cell-independent mechanisms [27] and also does
not stabilize mast cells under all conditions [28]. At this time,
evidence indicates that while mast cell degranulation may
contribute to CHS-induced hyperalgesia after 1 and 3 Ox
challenges, it is likely not the only regulator of sustained
mechanical sensitivity elicited by Ox-CHS at 24 hours. Ten or
more applications of Ox have been shown to increase mast cell
prevalence in the ear tissue of mice [29] and patients with
provoked vulvar pain have higher than normal mast cell
prevalence in their vulvar biopsy tissue [10-12]. In our ongoing
studies, we are currently examining mast cell dynamics in the
labiar tissue after 10 or more Ox challenges in sensitized
female mice.
Table 1. Percentages of mice showing hyperalgesic vulvar
responses (i.e. vulvar withdrawal thresholds ≤ 33% of
baseline) following single, and triple, labiar Ox or vehicle
challenge.
Time (h) 1 3 6 24 48 120 240
Ox/EtOH (1) 0 12.5 0 0 28.5 - -
Ox/Ox (1) 66.67 100 88.9 83.3 35.7 - -
Ox/EtOH (3) - - 34.80 40.90 - 57.10 44.40
Ox/Ox (3) - - 70.40 65.40 - 82.60 62.50
doi: 10.1371/journal.pone.0078673.t001
Labiar neutrophil influx remained elevated above baseline
levels 48 hours following 1 Ox challenge by which time vulvar
hyperalgesia had resolved. After 3 consecutive daily Ox
challenges, neutrophil influx was upregulated at 24 hours but
was indistinguishable from controls at 120 hours post-
challenge when hyperalgesia was present. Though neutrophils
can mediate pain responses following passive cutaneous
anaphylaxis in rats [26] and mast cell degranulation in mice
[17], neutrophil influx does not appear to be sufficient for Ox
CHS-induced vulvar hyperalgesia in ND4 mice. As repeated Ox
exposures are known to induce eosinophil recruitment into the
affected tissue [30], we also assessed levels of eosinophil
peroxidase (EPO) enzyme activity in the labiar tissue following
3 Ox challenges and found a ~3-fold increase of EPO in the
labia of Ox challenged mice over vehicle-challenged controls at
both 24 and 120 hours after the third challenge (Figure S5A).
Roles of eosinophils in pain cascades are poorly defined but
their known roles in tissue remodeling via induction of matrix
metallo-proteinase enzymes [31] suggest that models such as
ours that integrate atopy and hyperalgesia may provide
opportunities to dissect contributions of eosinophils to
modulation of pain sensitivity following extensive tissue
remodeling.
Inflammatory cytokines are known to mediate CHS [4,6] and
inflammatory pain in rodents [19–21]. Here, we found
pronounced upregulation in levels of IL-6 and IL-1β mRNAs
after 1 and 3 Ox challenges in sensitized mice 24 hours after
challenge. IL-6 transcripts were increased ~60-fold after a
single Ox challenge and ~75-fold after 3 Ox challenges. IL-1β
transcript levels were 15-fold and ~30-fold increased over
ethanol-challenge controls following 1 and 3 Ox challenges
respectively. These inflammatory cytokines are also increased
in vulvar biopsies from vulvar vestibulitis patients [32] but not in
vaginal lavages from patients vs. controls [33]. Genetic
differences in the production of IL-1β and IL-1Ra in vulvodynia
patients vs. controls [34] and enhanced IL-6 production in
vulvar fibroblasts obtained from vulvodynia patients have been
reported [35]. These observations further align our findings in
Ox-CHS hyperalgesia with clinical evidence for a role for these
inflammatory cytokines associated with allergies and vulvar
pain. Recent studies of vaginal secretions in vulvodynia
patients vs. controls have shown an increase in IL-4 levels in
patients [33]. After 3 Ox challenges, we found a very slight
upregulation in IL-4 transcripts in the labiar tissue and are
continuing to monitor the levels of this cytokine in the context of
>3 Ox challenges in studies ongoing in our laboratory. Given
this, and that we see detectable recruitment of eosinophils into
the labiar skin after 3 Ox challenges, we assessed mRNA
levels of Th2 cytokines interleukin-5 (IL-5) and interleukin-13
(IL-13) [36] and C-C motif chemokine 11/eotaxin (CCL11) 24
hours after the third Ox challenge. We found only a slight
upregulation in IL-13 mRNA levels in experimental vs. control
mice, and little to no change in IL-5 and CCL11 transcripts
(Figure S5B). Interestingly, no increases in levels of IL-5, IL-13
and CCL11 have been reported in vaginal secretions of
vulvodynia patients compared to controls [33].
CXCL2 transcripts showed an interesting pattern in our
studies. CXCL2 was the only cytokine gene upregulated over
Allergic Mechanical Hyperalgesia in Mice
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controls in the labia 48 hours after a single Ox challenge and
was dramatically increased (~160-fold) over ethanol controls 24
hours after 3 challenges. CXCL2 is also constitutively
expressed in the brain and can play a neuro-modulatory role
Figure 2.  Repeated (3x) labiar oxazolone challenge induces persistent vulvar mechanical hyperalgesia in female ND4
Swiss mice.  Ox-sensitized mice given three consecutive labiar challenges show increased mechanical hyperalgesia at 24 hours
and 120 hours (5 days) (A), an increase in myeloperoxidase activity at 24 hours (B), an upregulation in proinflammatory cytokine
transcript levels (C). Significances are compared to Ox/EtOH (* = p<0.05, ** = p<0.01 respectively). n=3 (myeloperoxidase assays)
or n=20-24 (hyperalgesia assays) mice per treatment group; data represent at least 2-3 independent experiments.
doi: 10.1371/journal.pone.0078673.g002
Allergic Mechanical Hyperalgesia in Mice
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[37]. Therefore CXCL2 may contribute to the lasting change in
mechanical sensitivity through the modulation of innervation of
allergen-challenged tissue that we see here.
Taken together, our characterization of labiar inflammation
points to a sustained change in pain sensitivity after resolution
of overt inflammation following 3 Ox challenges while acute
inflammation and pain are present together after a single Ox
Figure 3.  Labiar CGRP+ and PGP 9.5+ nerve density increases following single oxazolone challenge in sensitized
mice.  Ox-challenged sensitized mice show ~8-10-fold increased density of cutaneous CGRP+(A-D) and PGP 9.5+ (E-H) nerves at
48 hours after challenge. Significances are compared to Ox/EtOH (*** = p< 0.0001); and untreated controls (### = p< 0.0001). n=3
mice per treatment group.
doi: 10.1371/journal.pone.0078673.g003
Figure 4.  Labiar CGRP+ and PGP 9.5+ nerve density increases after three oxazolone challenges in sensitized mice.  Mice
challenged thrice with Ox show ~6-8-fold increased CGRP+ (A-D) and PGP 9.5+ (E-H) cutaneous nerve density 5 days after 3
consecutive daily Ox challenges. Significances are compared to Ox/EtOH (*** = p< 0.0001); and untreated controls (### = p<
0.0001). n=3 mice per treatment group.
doi: 10.1371/journal.pone.0078673.g004
Allergic Mechanical Hyperalgesia in Mice
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challenge. Clinical vulvodynia is a chronic pain condition
typically presenting without co-occurring overt inflammatory
events [8]. As early as 6 hours, 3 Ox challenges provoke a
smaller increase in IL-1β gene expression in the skin compared
to a single challenge. Neutrophil influx and cytokine gene
expression responses resolve by 5 days after 3 Ox challenges
even as vulvar mechanical sensitivity remains detectable in
challenged mice vs. controls. Therefore the model of vulvar
pain we establish here reflects the reduction of acute tissue
responses one would expect in chronic inflammation while
preserving changed hyperalgesic sensitivity of the vulvar
tissue.
Density of CGRP+ and PGP 9.5+ cutaneous nerve fibers
increased significantly in the labiar skin of Ox-challenged mice
supporting earlier findings in murine ear tissue [5] and echoing
similar observations in vulvodynia [11,12] and atopic dermatitis
patients [38]. A slightly lower nerve density at 5 days after 3
challenges vs. 48 hours after a single challenge suggests that
possible central nervous system reorganization [39] associated
with repeated allergen challenge may contribute to the
sustained hyper-innervation when immediate peripheral
inflammatory stimuli are no longer present. Treatment with the
tri-cyclic anti-depressant amitriptyline has been modestly
effective in the clinical management of vulvodynia [8]; in our
experiments, amitriptyline pre-treatment reduced vulvar
hyperalgesia at 1, 6 and 24 hours post-challenge in mice
(Figure S4). Amitriptyline abrogates neuropathic allodynia [40]
and formalin pain [41] in rats and may reduce Ox CHS-pain via
direct effects on nerve fibers [42] suggesting that increased
cutaneous nerve density may be a key regulator of allergic
vulvar hyperalgesia.
Mast cells and nerves are known to reside in close proximity
in tissues [43] mediated by adhesion molecules including N-
cadherin and cell adhesion molecule 1 [44,45]. We, and others
[5], show that 1-3 Ox challenges increase local nerve density,
while an increase in mast cell abundance at the challenge site
following 10 or more Ox challenges has been documented [29].
Furthermore, both mast cells and neurons are known to
regulate each other’s functions. Proximity to neurons enhances
FcεR1 expression on mast cells thus lowering the latter’s
activation and degranulation thresholds [46]. In turn, mast cell-
derived TNF-α and NGF can promote nerve elongation [5] and
lower the threshold of nociceptor firing [47]. Therefore, in
hyper-innervated allergic sites in Ox-challenged labia, mast
cell-neuron synapses can potentially regulate changes in pain
sensitivity in the periphery. Systemic mast cell degranulation
can be followed by changes in c-fos and pERK expression in
the spinal cord [48,49], indicating that mast cells may
contribute to central sensitization in nociceptive signaling.
Our findings recapitulate increased inflammatory cytokine
production [32], hyperinnervation of the vestibular tissue
[10–12] and heightened sensitivity to mechanical pressure [50]
seen in vulvodynia patients. We further corroborate recent
observations [15] that repeated vulvo-vaginal infection with
Candida albicans resulted in altered ano-genital mechanical
sensitivity of mice after resolution of active infection. While that
study did not investigate whether there was an allergic
response to C. albicans antigens in hyperalgesic mice, our
studies together provide strong evidence that even after
inflammation (allergic or infection-related) is resolved, tissue
innervation and pain perception can be altered in a sustained
manner. We are currently adapting our model of allergen-
evoked vulvar hyperalgesia to longer-term repeated allergen
challenges. Parameters influencing lasting hyperalgesic
responses in the vulva including the dynamics of immune cell
infiltration in the tissue during and after CHS, neuro-immune
interactions, changes in quality and nature of tissue cytokine
production are all areas of investigation that we, and others,
can build upon the foundation we present here to dissect the
mechanistic relationship between allergies and hyperalgesia in
mice.
As a diagnosis of exclusion [8], vulvodynia, like many
complex disorders, is likely a multivalent and multifactorial
condition with diverse underlying mechanisms, including
allergy, for different individuals. The synergy of epidemiological
[9,51], clinical [10–12] and pre-clinical studies [15] including
ours is required to dissect the complex nuances of this
underserved condition, elucidate the variety of possible
underlying causes and develop targeted therapies that will
allow physicians and patients to manage and treat vulvodynia
more successfully. Importantly, other complex pain conditions
are associated with allergies or elevated mast cell functions.
For example, individuals with a history of allergies are over-
represented in those suffering from migraine pain [52]. Men
who suffer from chronic pelvic pain syndrome are frequently
co-diagnosed with chronic prostatitis and show elevated levels
of mast cell mediators in prostatic secretions [53]. Therefore,
the particular line of investigation we initiate here will have
implications beyond vulvodynia as a tool to decipher the
complex contributions of allergic reactions to chronic pain
conditions.
Supporting Information
Figure S1.  Ox challenge is applied topically onto the labia
of sensitized mice. Mice were sensitized on Day 1 with 2% Ox
on the shaved flank. On Day 5, we challenged mice with 1%
Ox or vehicle (100% EtOH; 40µl) using a 50µl Hamilton syringe
barrel to apply either solution onto the shaved labiar skin
(cross-hatched region). To quantify gene expression,
cutaneous nerve density, and eosinophil peroxidase activity,
we used labia (red rectangle) excised after euthanasia, while a
slightly larger area (dotted circle) was used for
myeloperoxidase activity assays. [Artwork: Charles Cosimini].
(TIF)
Figure S2.  Neither stage of estrous nor Ox sensitization
alone alter vulvar mechanical sensitivity. Estrous stages of
mice were determined as previously described [54]. Briefly,
vaginal lavages were performed using 100 µL of double-
distilled H20, and vaginal smears prepared by cytospin on 5
consecutive days at the same time of day (noon) immediately
after von Frey measurements were taken. Vaginal smears
were stained with 0.1% crystal violet and relative ratios of the
predominant cell types were determined using an Olympus
CKX41SF inverted binocular microscope to determine the
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estrous stage of each mouse. Stages of the mice’s estrous
cycle (A) do not affect baseline vulvar mechanical sensitivity.
Ox sensitization alone, without challenge, (B) does not produce
hyperalgesia. Labiar oxazolone challenge does not alter
mechanical withdrawal thresholds of the hind paws in
sensitized mice (C). n = 7-12 per treatment group.
(TIF)
Figure S3.  IL-1β but not TNF-α transcripts are significantly
elevated in Ox-challenged mice over controls as early as 6
hours after 1 and 3 labiar Ox challenges. Sensitized mice
challenged once with labiar Ox show a ~ 60-fold elevation of
IL-1β mRNA levels and little difference in TNF-α transcript
levels in the labiar skin compared to mice challenged with
vehicle alone 6 hours after challenge (black bars). Similarly,
sensitized mice challenged 3 times with Ox on the labia have
12-fold increase in IL-1β and little to no change in TNF-α
mRNA compared to controls 6 hours after the third challenge
(white bars).
(TIF)
Figure S4.  Amitriptyline and sodium cromoglycate pre-
treatment reduce vulvar hyperalgesia in Ox-sensitized and
challenged ND4 Swiss mice. Sensitized mice pre-treated with
amitriptyline (10 mg/kg ; 100µl i.p. [55]) or sodium
cromoglycate (160 mg/kg; 100µl i.p.) 1 hour before Ox
challenge show reduced mechanical hyperalgesia at 1, 6, and
24h after Ox challenge. Significances are compared to
Ox/Sal/Ox (* = p<0.05,** = p<0.01, *** = p<0.0001). n=10 mice
per treatment group; data represent 2-3 independent
experiments.
(TIF)
Figure S5.  Three consecutive labiar oxazolone challenges
induce an increase in eosinophil activity in the labiar
tissue of female ND4 Swiss mice. Mice that received 3 labiar
Ox challenges following sensitization showed an increase in
eosinophil peroxidase activity in the labiar tissue at 24 hours
and 120 hours (A); to measure eosinophil peroxidase activity
(EPO), we adapted previously described methods [56,57];
excised labia were preserved at -80°C in 0.5%
hexadecyltrimethyl ammonium bromide in phosphate-buffered
saline, homogenized, freeze-thawed three times, centrifuged
twice, first at 4750 rpm and next at 14000 rpm for 4 minutes at
4°C, and 50µl of the supernatant mixed with 100µl of 16mM o-
phenylenediamene, 50mM-Tris-HCL, 0.01% H2O2. The reaction
was stopped with 1M H2SO4 after 15 minutes and OD
measurements taken at 490 nm. EPO activity was represented
as OD/g of wet tissue. At 24 hours after 3 Ox challenges, mice
showed a slight upregulation of IL-13 (Mm00434204_m1)
mRNAs in the labiar skin but there was little to no change in
eotaxin/CCL11 (Mm00441238_m1) and IL-5
(Mm00439646_m1) transcript levels by qRT-PCR analysis (B).
Significances are compared to Ox/EtOH (* = p<0.05, ** =
p<0.01, *** = p< 0.0001 respectively). n = 2-6 mice per
treatment group; data represent at least 2 independent
experiments.
(TIF)
Table S1.  Average raw cycle threshold (Ct) values
showing detectable IL-4 mRNA (Mm00445259_m1)
transcripts at 24 hours following triple Ox challenge in
sensitized mice.
(DOCX)
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